Gavin Giovannoni, MBBCh, PhD - Navigating and Pioneering High-Efficacy DMT Strategies: Optimizing Patient Outcomes in Multiple Sclerosis

Visit https://www.peervoice.com/GNN860 to view the entire programme with slides. After completing “Gavin Giovannoni, MBBCh, PhD - Navigating and Pioneering High-Efficacy DMT Strategies: Optimizing Patient Outcomes in Multiple Sclerosis”, participants will be able to: Differentiate between the unique characteristics and evidence associated with different high-efficacy disease-modifying therapies (HE DMTs) used in the management of patients with multiple sclerosis (MS); Evaluate clinical and real-world data surrounding the use of HE DMTs as early intervention treatment strategies in the management of patients with MS; and Implement new strategies to incorporate HE DMTs earlier in the sequencing of treatments for patients with MS.